PROM1 and sarcoma: Conversely, stableknockdown of Nanog using shRNA, which did not alter cell proliferation (Suppl.Fig. S1D), in sarcoma spheroid cellsresulted in decreased expression of CD133 as determined by western blot andimmunofluorescence (Suppl.